A total of five antitumor immune signatures were analyzed, including B cells, CD8+ T cells, human leukocyte antigen (HLA), interferon (IFN) response, and tumor-infiltrating lymphocytes (TILs). This evidence concerns the gene CD8A and neoplasm.